AR026705A1 - SHREDDED FORM - Google Patents
SHREDDED FORMInfo
- Publication number
- AR026705A1 AR026705A1 ARP000106385A ARP000106385A AR026705A1 AR 026705 A1 AR026705 A1 AR 026705A1 AR P000106385 A ARP000106385 A AR P000106385A AR P000106385 A ARP000106385 A AR P000106385A AR 026705 A1 AR026705 A1 AR 026705A1
- Authority
- AR
- Argentina
- Prior art keywords
- refers
- compound
- pharmaceutically acceptable
- reduced particle
- particle size
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000002245 particle Substances 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- -1 4-tert-butoxycarbonylaminophenyl Chemical group 0.000 abstract 1
- 208000031773 Insulin resistance syndrome Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente se refiere a un tamano de partícula reducido del compuesto ácido 3-{4-[2-(4-terc-butoxicarbonilaminofenil)etoxi]fenil}-(S)-2-etoxi propanoico,segun formula (1) o su sal farmacéuticamente aceptable o un solvato de cualquiera de ellos. La p resente también se refiere a los métodos para tratar una o máscondiciones asociadas con el Síndrome de Resistencia a la Insulina usando la forma de tamano de partícula reducido del compuesto, o su sal farmacéuticamenteaceptable para la fabricacion de un medicamento para usar para una o más de dichas condiciones. La presente también se refiere a las composicionesfarmacéuticas que contienen la forma de tamano de partícula reducido del compuesto, o su sal farmacéuticamente aceptable, o su solvato, como ingrediente activo, así como también se refiere a los procesos para la fabricacion de la forma de tamano de partícula reducido del compuesto o su sal farmacéuticamente aceptable.This refers to a reduced particle size of the compound 3- {4- [2- (4-tert-butoxycarbonylaminophenyl) ethoxy] phenyl} - (S) -2-propanoic ethoxy, according to formula (1) or its salt Pharmaceutically acceptable or a solvate of any of them. The present also refers to methods for treating one or more conditions associated with Insulin Resistance Syndrome using the reduced particle size form of the compound, or its pharmaceutically acceptable salt for the manufacture of a medicament for use for one or more of these conditions. This also refers to pharmaceutical compositions that contain the reduced particle size form of the compound, or its pharmaceutically acceptable salt, or its solvate, as an active ingredient, as well as refers to the processes for manufacturing the size form. of reduced particle of the compound or its pharmaceutically acceptable salt.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9904412A SE9904412D0 (en) | 1999-12-03 | 1999-12-03 | Comminuted form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026705A1 true AR026705A1 (en) | 2003-02-26 |
Family
ID=20417977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000106385A AR026705A1 (en) | 1999-12-03 | 2000-12-01 | SHREDDED FORM |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR026705A1 (en) |
| AU (1) | AU2034701A (en) |
| CO (1) | CO5271723A1 (en) |
| SE (1) | SE9904412D0 (en) |
| WO (1) | WO2001040166A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| RU2235094C2 (en) | 1997-10-27 | 2004-08-27 | Др. Редди`З Лабораториз Лимитед | Beta-aryl-alpha-hydroxy-substituted alkylcarboxylic acids, methods for their preparing, intermediate compounds, methods for their preparing, pharmaceutical composition, methods for treatment or prophylaxis of diseases based on new compounds |
| AU752059B2 (en) | 1997-10-27 | 2002-09-05 | Dr. Reddy's Laboratories Limited | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| US6130214A (en) | 1997-10-27 | 2000-10-10 | Dr. Reddy's Research Foundation | Benzothiazin and benzoxazin derivatives; their preparation and uses |
| US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| KR20010085876A (en) | 1998-10-29 | 2001-09-07 | 닥터 레디스 리서치 파운데이숀 | An improved process for the preparation of new antidiabetic agents |
| US6531596B1 (en) | 1998-10-29 | 2003-03-11 | Dr. Reddy's Laboratories Ltd. | Process for the preparation of new antidiabetic agents |
| US6897199B2 (en) | 2001-02-05 | 2005-05-24 | Dr. Reddy's Laboratories Ltd. | Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9801990D0 (en) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
| MA26634A1 (en) * | 1998-06-04 | 2004-12-20 | Astra Ab | NOVEL 3-ARYL PROPIONIC ACID DERIVATIVES AND THE LIKE |
-
1999
- 1999-12-03 SE SE9904412A patent/SE9904412D0/en unknown
-
2000
- 2000-11-29 WO PCT/SE2000/002380 patent/WO2001040166A1/en active Application Filing
- 2000-11-29 CO CO00091394A patent/CO5271723A1/en not_active Application Discontinuation
- 2000-11-29 AU AU20347/01A patent/AU2034701A/en not_active Abandoned
- 2000-12-01 AR ARP000106385A patent/AR026705A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001040166A1 (en) | 2001-06-07 |
| AU2034701A (en) | 2001-06-12 |
| CO5271723A1 (en) | 2003-04-30 |
| SE9904412D0 (en) | 1999-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029456A1 (en) | SHREDDED FORM | |
| AR072755A2 (en) | COMPRESSED DRUG LOAD COMPOUND 4- (4-METHYLPIPERAZIN-1-ILMETILE) -N- [4-METHYL-3- (4-PIRIDIN-3-IL) PIRIMIDIN-2-ILAMINO) PHENYL] -BENZAMIDA | |
| EA201000643A1 (en) | SUBSTITUTED PRODUCTION OF ETHYLENEDIAMIN FOR THE TREATMENT OF MYCOBACTERIAL DISEASES AND PHARMACEUTICAL COMPOSITION ON ITS BASIS | |
| NO20076613L (en) | Pharmaceutical Formulations and Their Use | |
| CO6160236A2 (en) | QUINASE INHIBITOR | |
| GT200000216A (en) | OXAZOLIDINONES REPLACED AND ITS USE. | |
| AR067495A1 (en) | PHARMACEUTICAL COMPOSITIONS AND PROCEDURE DRY EYE DISORDER TREATMENTS | |
| NO20060126L (en) | Substituted arylthiourea derivatives useful as inhibitors of viral replication | |
| AR056575A1 (en) | COMPOSITE OF (ALPHA) -AMINOCARBOXYAMIDE THAT IS 5- (4 - [[(2-FLUOROPHENYL) METHYL] OXI] PHENYL) PROLINAMIDE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCESS TO PREPARE IT | |
| AR048431A1 (en) | GALENIC FORMULATIONS OF ORGANIC COMPOUNDS | |
| GT200100183A (en) | DERIVATIVES OF QUINOLINA AND QUINAZOLINA. | |
| AR054234A1 (en) | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT | |
| AR063707A1 (en) | CERTAIN AMIDAS REPLACED, THE USE OF THE SAME FOR THE TREATMENT OF DISEASES MEDIATED BY THE INHIBITION OF THE ACTIVITY OF BTK AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM. | |
| PT1119543E (en) | N-ARALHYLAMINOTETRALINES AS LIGANDS FOR NEUROPEPTIDE AND Y5 RECEPTOR | |
| SE0301882D0 (en) | New use I | |
| HN2004000232A (en) | "PIRROLO DERIVATIVES (3,4-C) PIRAZOL ACTIVE AS QUINASE INHIBITORS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM." | |
| GT200600163A (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
| AR033688A1 (en) | RECONSTITUABLE PARENTERAL COMPOSITION | |
| UY27886A1 (en) | PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO. | |
| AR062393A1 (en) | USE OF DERIVATIVE OF 2.5-DIHIDRIXIBENCENO FOR THE TREATMENT OF ARTHRITIS AND PAIN | |
| UY29085A1 (en) | PIRIMIDINE DERIVATIVES 4-SULFONAMID SUBSTITUTED, INTERMEDIATE COMPOUNDS FOR PREPARATION, PREPARATION PROCEDURES, MEDICINAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
| UY27018A1 (en) | PIRIMIDINE DERIVATIVES | |
| AR007021A1 (en) | DERIVATIVES OF 3-DESCLADINOSA-2,3-ANHIDROERITROMICINA, PROCEDURES FOR ITS PREPARATION, COMPOUNDS FOR ITS EXCLUSIVE USE IN SUCH PROCEDURES AND PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION TO TREAT BACTERIAL INFECTIONS AND THE USE OF THESE COMPUTERS | |
| AR026705A1 (en) | SHREDDED FORM | |
| AR048336A1 (en) | HYDROCLORIDE OF (4- (5-AMINOMETIL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL) - (4-BROMO-3-METHYL-5-PROPOXI-TIOFEN-2-IL) -METANONE AS AN INHIBITOR OF THE MASTOCYT TRIPTASE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |